Arpad I.
- Country
- Hungary
- Department
- Belgyógyászati Klinika, Hematológia
Research Overview
- Phase 3 Study of Lisaftoclax (APG-2575) and Acalabrutinib in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients
- Phase 3 Randomized Study of Epcoritamab Plus R-CHOP Versus R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients
- Efficacy and Safety Evaluation of Rapcabtagene Autoleucel Versus Rituximab in Severe Refractory Diffuse Cutaneous Systemic Sclerosis
Data & Insights
Has run more than one trial at 71 of 267 partner sites.
Specializations
Oncology & Immunotherapy
The investigator specializes in treating advanced renal cell carcinoma through innovative immunotherapy combinations. Their research explores novel therapeutic approaches using nivolumab and ipilimumab for patients with metastatic kidney cancer.
- Renal Cell Carcinoma Management
- Combination Immunotherapy
- Advanced Kidney Cancer Treatment
The investigator focuses on developing treatment strategies for previously untreated renal cell cancer patients, evaluating survival outcomes and disease progression.
Hematologic Oncology
The investigator concentrates on treating Diffuse Large B-Cell Lymphoma (DLBCL), investigating innovative therapeutic combinations. Their work involves evaluating epcoritamab in combination with standard lymphoma treatments.
- DLBCL Treatment Innovation
- Combined Therapy Approaches
- Novel Antibody Treatments
Their research explores enhanced treatment protocols for newly diagnosed DLBCL patients, particularly focusing on high-risk cases requiring intensive therapeutic intervention.
Therapeutic Development
The investigator's work encompasses targeted therapy development across multiple cancer types. Their expertise includes evaluating combination treatment protocols and assessing therapeutic efficacy in oncology.
- Treatment Protocol Development
- Cancer Therapy Assessment
- Progressive Disease Management
Their research interests extend to evaluating progression-free survival and developing optimized treatment strategies for cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.